Latest Home hemodialysis Stories
LAWRENCE, Mass. and PHILADELPHIA, Nov. 11, 2011 /PRNewswire/ -- Booth # 407 at The American Society of Nephrology (ASN)'s Kidney Week 2011 -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its Medisystems division has won a multi-year contract to supply the Vasc-Alert(TM) Access Surveillance Solution to Atlantic Dialysis Management Services centers. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) "Robust...
LAWRENCE, Mass. and PHILADELPHIA, Nov. 10, 2011 /PRNewswire/ -- Booth # 407 at The American Society of Nephrology (ASN)'s Kidney Week 2011 -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, today announced that Ashita Tolwani, M.D., and William Fissell, M.D., recipients of a NxStage Research Grant, conducted a multi-center study evaluating the removal of Piperacillin during continuous renal replacement therapy (CRRT) in an acute setting for...
LAWRENCE, Mass. and PHILADELPHIA, Nov. 10, 2011 /PRNewswire/ -- Booth # 407 at The American Society of Nephrology (ASN)'s Kidney Week 2011 -- NxStage(®) Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) study, showing patients experience a better overall quality of life while undergoing more frequent...
LAWRENCE, Mass., Nov. 8, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that former NxStage® System One(TM) patient David RUSH, 29, is celebrating the one-year anniversary of his successful kidney transplant during a special event on November 9, 2011. RUSH received the transplant following more than two years of more frequent home hemodialysis with the System One. (Logo:...
LAWRENCE, Mass., Nov. 2, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Barry M. Straube, M.D., a member of its Board of Directors, was honored with the Mark Zawiski Memorial Award from the National Renal Administrators Association (NRAA). The award honors outstanding leadership in the End Stage Renal Disease (ESRD) community and was presented at the NRAA annual conference in New Orleans. (Logo:...
Clinics in low-income urban areas may get unfairly penalized under Medicare payment system Patient characteristics affect whether dialysis clinics achieve treatment success and receive Medicare reimbursement How well kidney disease patients follow their prescribed treatments has the greatest impact Dialysis clinics in low-income urban areas provide care to more patients who don't follow their prescribed treatments; these clinics get unfairly penalized Dialysis...
LAWRENCE, Mass., Oct. 21, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced it ranked 141 on Deloitte's Technology Fast 500(TM) ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year revenue growth during the period from 2006-2010. NxStage Medical, Inc. grew 761 percent during this...
NEW YORK, Oct. 13, 2011 /PRNewswire-USNewswire/ -- The Rogosin Institute is bringing dialysis closer to home for patients who need it by opening a new dialysis center in Auburndale, Queens. The Opening Reception, held Wednesday October 12, 2011 was attended by Helen Marshall, Queens Borough President, Paola Miceli, Director, Health, Human and Senior Services and other government officials. The center can accommodate 232 patients. In addition to dialysis, the center will provide home...
LAWRENCE, Mass., Oct. 5, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM) is a leading manufacturer of innovative dialysis products and together with its patients and their care partners is leading the home hemodialysis revolution. Because of their passion and enthusiasm, NxStageUsers, together with thousands of other patients, continue to fuel the growth of NxStage by helping to change the dialysis treatment paradigm and give dialysis patients greater access to quality care,...
LAWRENCE, Mass., Oct. 3, 2011 /PRNewswire/ -- NxStage(®) Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today applauded the efforts of its home hemodialysis patients together with the National Kidney Foundation (NKF) and Dialysis Patient Citizens (DPC), in advocating for improvements in the quality of care for end stage renal disease (ESRD) patients with lawmakers. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) NxStage home...
